MEDP
HealthcareMedpace Holdings, Inc.
$586.83
+$15.81 (+2.77%)
Jan 5, 2026
Price History (1Y)
Analysis
Medpace Holdings, Inc. is a publicly traded company listed on the Healthcare sector, within the Diagnostics & Research industry. The company has a substantial market presence, with a market capitalization of $16.53 billion and annual revenue of $2.36 billion. From a financial perspective, Medpace demonstrates strong profitability, with gross margins reaching 69.6% and operating margins at 21.5%. Net income for the trailing twelve months amounts to $432.92 million, while EBITDA stands at $535.54 million. The company's balance sheet shows a relatively low level of debt, totaling $143.97 million, compared to its cash holdings of $285.35 million. Valuation metrics indicate that Medpace trades at a premium, with a price-to-earnings ratio (TTM) of 39.84 and a forward P/E of 35.54. The company has experienced significant revenue growth over the past year, reaching 23.7%, while earnings have grown by 28.2%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Visit website →Key Statistics
- Market Cap
- $16.53B
- P/E Ratio
- 39.84
- 52-Week High
- $626.25
- 52-Week Low
- $250.05
- Avg Volume
- 281.29K
- Beta
- 1.44
Company Info
- Industry
- Diagnostics & Research
- Exchange
- NMS
- Country
- United States
- Employees
- 6,200